Kathy Gately
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- Peptidase Inhibition and Analysis
Papers in
-
- PI3K/AKT/mTOR signaling in cancer 7
- Cancer therapeutics and mechanisms 6
-
- Lung Cancer Treatments and Mutations 17
- Lung Cancer Diagnosis and Treatment 12
- Co-authors
- Kenneth J. O’Byrne (60 shared papers)Susan Heavey (16 shared papers)Anne‐Marie Baird (11 shared papers)Martin P. Barr (20 shared papers)Nael Al-Sarraf (8 shared papers)Stephen P. Finn (19 shared papers)P. Godwin (5 shared papers)Julie Lucey (4 shared papers)
- Journals
- Lung Cancer (11 papers)Journal of Clinical Oncology (6 papers)Journal of Thoracic Oncology (6 papers)Cancers (3 papers)Clinical Lung Cancer (3 papers)
- Partner nations
- IrelandAustraliaUnited Kingdom
In The Last Decade
Kathy Gately
77 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 103
- Cancer Research 301
- Oncology 420
- Pulmonary and Respiratory Medicine 429
- Pathology and Forensic Medicine 167
- Molecular Biology 684
Countries citing papers authored by Kathy Gately
This map shows the geographic impact of Kathy Gately's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kathy Gately with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kathy Gately more than expected).
Fields of papers citing papers by Kathy Gately
This network shows the impact of papers produced by Kathy Gately. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kathy Gately. The network helps show where Kathy Gately may publish in the future.
Co-authors
The 25 scholars most cited alongside Kathy Gately, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 78 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 240 | |
| 2 | 2008 | 127 | |
| 3 | 2016 | 99 | |
| 4 | 2008 | 91 | |
| 5 | 2021 | 85 | |
| 6 | 2016 | 76 | |
| 7 | 2015 | 76 | |
| 8 | 2020 | 70 | |
| 9 | 2013 | 66 | |
| 10 | 2015 | 66 | |
| 11 | 2017 | 64 | |
| 12 | 2007 | 58 | |
| 13 | 2007 | 55 | |
| 14 | 2015 | 55 | |
| 15 | 2023 | 48 | |
| 16 | 2011 | 30 | |
| 17 | 2019 | 29 | |
| 18 | 2011 | 29 | |
| 19 | 2019 | 27 | |
| 20 | 2014 | 26 |
About Kathy Gately
Kathy Gately is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Oncology, Cancer Research and Pathology and Forensic Medicine, having authored 78 papers that have together received 1.8k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (17 papers), Lung Cancer Diagnosis and Treatment (12 papers), Cancer Mechanisms and Therapy (9 papers), PI3K/AKT/mTOR signaling in cancer (7 papers), NF-κB Signaling Pathways (6 papers), Cancer therapeutics and mechanisms (6 papers), Peptidase Inhibition and Analysis (5 papers) and Cancer Genomics and Diagnostics (5 papers). The work is most often cited by research in Cancer Research (301 citations), Oncology (420 citations), Pulmonary and Respiratory Medicine (429 citations), Pathology and Forensic Medicine (167 citations) and Molecular Biology (684 citations). Kathy Gately has collaborated with scholars based in Ireland, Australia and United Kingdom. Frequent co-authors include Kenneth J. O’Byrne, Susan Heavey, Anne‐Marie Baird, Martin P. Barr, Nael Al-Sarraf, Stephen P. Finn, P. Godwin, Julie Lucey, Sinéad Cuffe and Vincent Young. Their work appears in journals such as Lung Cancer, Journal of Clinical Oncology, Journal of Thoracic Oncology, Cancers and Clinical Lung Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.